Este programa de colaboración público-privada es uno de los mejores ejemplos de promoción de la I+D continental en el objetivo de promover proyectos innovadores. Los fondos provienen del programa Horizonte 2020 de la Unión Europea y pueden concurrir universidades, centros públicos de investigación, pequeñas y medianas empresa y organizaciones de pacientes. La otra mitad del presupuesto viene de las grandes empresas farmacéuticas que participan en la convocatoria. Su objetivo desde 2014 es fomentar y financiar la colaboración en proyectos finales de elaboración de medicamentos.
Topics de esta edición:
• Topic 1: Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials
• Topic 2: How big data could support better diagnosis and treatment outcomes for prostate cancer (part of the Big Data for Better Outcomes programme)
• Topic 3: Improving the care of patients suffering from acute or chronic pain (this topic includes three subtopics on patient reported outcomes; biomarkers; and chronic pelvic pain)
• Topic 4: Creation of a pan-European paediatric clinical trials network
• Topic 5: Biomanufacturing 2020: development of innovative high throughput analytical tools and methods to characterize cell culture fluid during development and commercial cell culture processes
• Topic 6: Unlocking the solute carrier gene-family for effective new therapies (unlock SLCs)
• Topic 7: Patient perspectives in medicines lifecycle
• Topic 8: Personalised medicine approaches in autism spectrum disorders
Vetinnova © 2024